Performance of CryoValve SG decellularized pulmonary allografts compared with standard cryopreserved allografts.

@article{Konuma2009PerformanceOC,
  title={Performance of CryoValve SG decellularized pulmonary allografts compared with standard cryopreserved allografts.},
  author={Takeshi Konuma and Eric J. Devaney and Edward L. Bove and Sarah K. Gelehrter and Jennifer C. Hirsch and Zarry Tavakkol and Richard G. Ohye},
  journal={The Annals of thoracic surgery},
  year={2009},
  volume={88 3},
  pages={849-54; discussion 554-5}
}
BACKGROUND There is no ideal option for pulmonary valve replacement in children. Cryopreserved pulmonary allografts frequently demonstrate early valve regurgitation and may elicit an immune response. To improve these shortcomings, the SynerGraft process (CryoLife, Kennesaw, GA) decellularizes an allograft, leaving only connective tissue, which then becomes repopulated with host cells. A previous study at our institution demonstrated superior short-term durability of the SynerGraft-processed… CONTINUE READING